Advertisement

Topics

French Gene Therapy Biotech Raises a Huge €37.5M in Series A

04:50 EDT 4 May 2017 | Labiotech.eu

Vivet Therapeutics has raised a huge €37.5M in Series A to help bring a new gene therapy technology for rare liver diseases to the clinic.  Vivet Therapeutics has managed to attract some of the hottest biotech investors in Europe in ...

This awesome article French Gene Therapy Biotech Raises a Huge €37.5M in Series A appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: French Gene Therapy Biotech Raises a Huge €37.5M in Series A

NEXT ARTICLE

More From BioPortfolio on "French Gene Therapy Biotech Raises a Huge €37.5M in Series A"

Quick Search
Advertisement
 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...